URGN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

UroGen Pharma (URGN) Earnings Date & Reports

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

URGN is expected to report earnings to fall 1.68% to -78 cents per share on May 08

UroGen Pharma URGN Stock Earnings Reports

Q1'25

Est.

$-0.79

Q4'24

Missed

by $0.03

Q3'24

Beat

by $0.27

Q2'24

Missed

by $0.08

Q1'24

Missed

by $0.10

The last earnings report on March 10 showed earnings per share of -80 cents, missing the estimate of -76 cents. With 118.84K shares outstanding, the current market capitalization sits at 485.83M.

View a ticker or compare two or three

Compare

URGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For URGN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for URGN (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of therapies for urological pathologies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

400 Alexander Park Drive

Phone

+1 646 768-9780

Employees

201

Web

https://www.urogen.com